U.S., Dec. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07296146) titled 'Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients.' on Nov. 19.
Brief Summary: The goal of this clinical trial is to assess whether probiotic supplementation can improve the hematological response of CKD patients to erythropoietin therapy and prevent or reduce erythropoietin resistance. The main questions it aims to answer are:
Can probiotic be used as an adjuvant strategy in anemia management and increasing ESA responsiveness in CKD? What medical problems do participants have when taking probiotic? Researchers will compare Erythropoietin only with Erythropoietin + Probiotic to see if Probiotic aids in...